Insights & Resources › Case Studies
Geographic Coverage: Global | Published On: | Reads: 4
Enabled a major pharmaceutical company to expand its oncology drug portfolio across Asia-Pacific markets through regulatory and market access intelligence.
Client: PharmaGlobal Inc.
A major pharmaceutical company wanted to expand its oncology drug portfolio in Asia-Pacific markets. The client needed to understand regulatory requirements, competitive dynamics, and healthcare system access pathways across China, Japan, South Korea, and India.
Thinkvia Research provided end-to-end market intelligence covering regulatory approval pathways, pricing and reimbursement scenarios, and distribution channel analysis. We identified key opinion leaders and potential distribution partners.
The client obtained regulatory approvals in 3 of 4 target markets within 24 months. Product launch execution exceeded targets by 25%, with first-year sales reaching $120M across the region.